Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023
Evolutionary dynamics of early and late mutational signatures in metastatic cancer
Anastasia Yankovskiy1,2, Sudhir Kumar1,2, Sayaka Miura1,2,3
1Department of Biology, Temple University, Philadelphia, PA, United States.
Abstract:
Cancer genomes accumulate somatic mutations over time, influenced by both intrinsic and extrinsic mutational processes. In metastatic cancer, disseminated tumor cells may acquire additional mutations at metastatic sites, shaped by extrinsic factors distinct from those at the primary tumor. As a result, cancer genomes at metastatic sites may bear mutational signatures originating from both primary and metastatic environments. However, the patterns and relative contributions of mutational signatures specific to metastatic sites remain poorly understood. To investigate this, we analyzed mutational signatures from seven metastatic cancer patients. We observed distinct mutational patterns between early and late mutation profiles within individual patients, where the early and late categories were based on their relative timing during tumor evolution. Early mutations were often dominated by a single mutational signature that accounted for more than half of the total signature burden. These dominant signatures tended to be shared among tumors of the same cancer type, suggesting that early mutations in metastatic cancers may be shaped by a single, highly active mutational process at the primary tumor site. In contrast, late mutations were often more poorly decomposed into distinct mutational signatures, reflecting more complex and diverse compositions. Overall, early mutations tended to preserve clearer signals of their origin.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell

